Cargando…

A Novel Serum 4-microRNA Signature for Lung Cancer Detection

The aim of this study was to identify differentially-expressed miRNAs in the serum of non-small cell lung cancer (NSCLC) patients that might be a clinically-useful tool for lung cancer early detection. We performed miRNA expression profile analysis using TaqMan OpenArray Human panel in a discovery s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nadal, Ernest, Truini, Anna, Nakata, Asuka, Lin, Jules, Reddy, Rishindra M., Chang, Andrew C., Ramnath, Nithya, Gotoh, Noriko, Beer, David G., Chen, Guoan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378885/ https://www.ncbi.nlm.nih.gov/pubmed/26202143 http://dx.doi.org/10.1038/srep12464

Ejemplares similares

Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection
por: Murlidhar, Vasudha, et al.
Publicado: (2016)

Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer
por: Yang, Xia, et al.
Publicado: (2019)

Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model
por: Zhang, Zhuo, et al.
Publicado: (2014)

MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer
por: He, Yanli, et al.
Publicado: (2015)

Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer
por: Andrade, Fernando, et al.
Publicado: (2020)

Transcriptome Meta-Analysis of Lung Cancer Reveals Recurrent Aberrations in NRG1 and Hippo Pathway Genes
por: Dhanasekaran, Saravana M., et al.
Publicado: (2014)

(18)F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer
por: Heiden, Brendan T., et al.
Publicado: (2018)

Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer
por: Feng, Shumei, et al.
Publicado: (2017)

On‐Chip Biogenesis of Circulating NK Cell‐Derived Exosomes in Non‐Small Cell Lung Cancer Exhibits Antitumoral Activity
por: Kang, Yoon‐Tae, et al.
Publicado: (2021)

Image directed lymph node sampling for lung cancer staging
por: Quint, Leslie E, et al.
Publicado: (2014)

The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation
por: Yan, Qiuliang, et al.
Publicado: (2020)

A serum microRNA signature for enhanced selection of people for lung cancer screening
por: Yu, Haixin, et al.
Publicado: (2022)

A panel of microRNA signature in serum for colorectal cancer diagnosis
por: Zhu, Mingxia, et al.
Publicado: (2017)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer
por: Zhang, Jie, et al.
Publicado: (2017)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
por: Zhang, Zhuo, et al.
Publicado: (2015)

Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas
por: Ferrer-Torres, Daysha, et al.
Publicado: (2016)

Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models
por: Beheshti, Afshin, et al.
Publicado: (2019)

Identification of a serum three-microRNA signature for cervical cancer diagnosis
por: Cao, Min-Min, et al.
Publicado: (2021)

Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
por: Sankar, Kamya, et al.
Publicado: (2021)

Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus
por: Craig, Michael P., et al.
Publicado: (2020)

The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?
por: Weinberg, Frank, et al.
Publicado: (2020)

MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 Deletion
por: Ju, Lixia, et al.
Publicado: (2017)

Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer
por: Zhu, Xinping, et al.
Publicado: (2021)

Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer
por: Hennessey, Patrick T., et al.
Publicado: (2012)

A novel serum microRNA signature to screen esophageal squamous cell carcinoma
por: Huang, Zebo, et al.
Publicado: (2016)

Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma
por: Liu, Hai-Ning, et al.
Publicado: (2017)

Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer
por: Liu, Hai-Ning, et al.
Publicado: (2018)

High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients
por: Zeinali, Mina, et al.
Publicado: (2020)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

A pilot study on differential expression of microRNAs in the ventromedial prefrontal cortex and serum of sows in activity restricted crates or activity free pens
por: Yin, Guoan, et al.
Publicado: (2019)

MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma
por: Yiming, Reheman, et al.
Publicado: (2021)

Correction: Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer
por: Hennessey, Patrick T., et al.
Publicado: (2012)

Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma
por: Lv, Shaogang, et al.
Publicado: (2017)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: GUO, JING, et al.
Publicado: (2016)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

Four-microRNA signature for detection of type 2 diabetes
por: Yan, Li-Na, et al.
Publicado: (2020)

Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human
por: Krauskopf, Julian, et al.
Publicado: (2017)

Identification of serum microRNA signatures associated with autism spectrum disorder as promising candidate biomarkers
por: Kichukova, Tatyana, et al.
Publicado: (2021)

Diagnostic implication of a circulating serum-based three-microRNA signature in hepatocellular carcinoma
por: Yousuf, Tahira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cg5hcjpq978vior0h9ckkihebp